CLINICAL OBSERVATION OF THE USE OF ORAL VINORELBINE IN THE TREATMENT OF DISSEMINATED ESTROGEN-RECEPTORPOSITIVE, HER2-NEGATIVE BREAST CANCER. World Bulletin of Social Sciences, [S. l.], v. 7, p. 1–4, 2022. Disponível em: https://scholarexpress.net/index.php/wbss/article/view/514. Acesso em: 31 mar. 2026.